gorodenkoff / iStock via Getty Images
(gorodenkoff / iStock via Getty Images)
Quick Read
-
iShares Exponential Technologies ETF (XT) spreads capital across 500+ holdings with no single position exceeding 3% of assets.
-
XT returned 22.63% over the past year, outperforming both QQQ and SPY benchmarks.
-
XT’s five-year gain of 31% trails QQQ’s 83% due to diversification during concentrated mega-cap leadership.
-
A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here.
Innovation-focused investors face a persistent dilemma: how to capture exposure to disruptive technologies without overpaying for hype or concentrating too heavily in mega-cap names. iShares Exponential Technologies ETF (NASDAQ:XT) attempts to solve this by spreading capital across 500+ holdings targeting AI, genomics, robotics, and other exponential-growth sectors. After a decade in the market, the fund’s track record reveals whether this diversified innovation bet delivers on its promise.
The ETF’s Intended Portfolio Role
XT positions itself as a core technology and healthcare growth sleeve for investors who want broader innovation exposure than traditional tech indexes provide. The fund allocates 30.2% to information technology and 16% to healthcare, with meaningful positions in semiconductors, cybersecurity, biotech, and cloud infrastructure. Top holdings include Eli Lilly (NYSE:LLY) (2.82%), Tesla (NASDAQ:TSLA) (2.78%), and NVIDIA (NASDAQ:NVDA) (2.23%), but no single position exceeds 3%, creating a more balanced profile than concentrated tech funds.
The fund targets capital appreciation through businesses scaling AI chips, gene therapies, electric vehicles, and enterprise software. Its 43% annual turnover reflects active rebalancing to maintain exposure to emerging leaders. With $3.7 billion in assets and a 0.46% expense ratio, the fund offers institutional-quality access at a reasonable cost.
Does It Deliver?
Performance tells a mixed story. Over the past year, XT returned 22.63%, meaningfully outpacing both Invesco QQQ Trust (NASDAQ:QQQ) and SPDR S&P 500 ETF Trust (NYSEARCA:SPY) over the same period. The outperformance likely reflects XT’s broader sector exposure catching tailwinds outside the mega-cap names that dominate QQQ. Year-to-date in 2026, that momentum has continued, with XT up 3.91% while QQQ has slipped into negative territory.
The five-year record tells a different story. XT’s cumulative gain of roughly 31% badly trails QQQ’s 83% over the same period, a gap that reflects a specific market dynamic: the 2021–2026 cycle was dominated by a narrow group of mega-cap AI and cloud names that QQQ concentrates heavily. Because XT spreads capital across 500+ holdings to reduce single-stock risk, it structurally limits its ability to benefit when just five or ten companies drive the majority of index returns. That diversification is a feature in volatile or sector-rotating markets, but a drag during sustained mega-cap rallies.
The Tradeoffs
XT’s 0.76% dividend yield makes it unsuitable for income investors. The fund distributed a $5.33 per share payment in December 2025, but this appears to be a special capital gains distribution rather than sustainable income. Sector concentration creates cyclical risk, and international holdings add currency and geopolitical exposure that domestic-focused investors may not want. Active rebalancing also introduces tracking error, as performance depends partly on the manager’s sector timing decisions.
XT is a broadly diversified innovation fund that spreads exposure across 500+ holdings in technology, healthcare, and adjacent sectors, with no single position exceeding 3%. Its recent one-year performance has been strong relative to major benchmarks, while its five-year record reflects the structural tradeoffs of wide diversification during a period of concentrated mega-cap leadership.
Data Shows One Habit Doubles American’s Savings And Boosts Retirement
Most Americans drastically underestimate how much they need to retire and overestimate how prepared they are. But data shows that people with one habit have more than double the savings of those who don’t.
And no, it’s got nothing to do with increasing your income, savings, clipping coupons, or even cutting back on your lifestyle. It’s much more straightforward (and powerful) than any of that. Frankly, it’s shocking more people don’t adopt the habit given how easy it is.
